Short communication: Towards saliva‐based screening for sleeping sickness?

Abstract

Summary A pilot study was carried out on the detection of trypanosome‐specific antibodies in saliva for diagnosis of sleeping sickness. All twenty‐three saliva samples of parasitologically confirmed Trypanosoma brucei gambiense patients tested positive in an indirect enzyme‐linked immunosorbent assay, whereas all 14 saliva samples of a negative control group remained negative. Trypanosome‐specific antibody levels in patient saliva correlated with antibody levels in serum, but were about 250‐fold lower. Eight of 23 undiluted saliva samples of sleeping sickness patients tested positive in CATT/T. b. gambiense and two of 23 in LATEX/T. b. gambiense. All fourteen saliva samples of the negative control group were also positive in CATT/T. b. gambiense, as were four of 14 in LATEX/T. b. gambiense. CATT and LATEX were thus inappropriate for antibody detection in saliva. These results indicate that trypanosome‐specific antibody detection in saliva is possible. This could lead to the development of a simple, non‐invasive, reliable saliva field test for diagnosis of sleeping sickness.

Human African Trypanosomiasis Diagnosis in First-Line Health Services of Endemic Countries, a Systematic Review

“…Test sample may be serum, plasma or saliva, either fresh or on filter paper. Reported sensitivity with different kinds of samples ranges from 82·8% to 100%, specificity from 94·7% to 100% [13], [14], [20], [36], [37]. Performing ELISA tests is time-consuming, technically demanding and expensive; moreover ELISA tests are not an individual format tests but are performed in batches of at least 50 samples.…”

Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?

“…Attempts to identify new antigens should result in more specific and sensitive tests for serodiagnosis of the disease, while changes in test format (i.e., the development of non-invasive saliva tests [8]) should result in more user-friendly tests. Much progress has been made in the development of molecular tools.…”

Tropical dermatology: Tropical diseases caused by protozoa

“…PCR/CSF appeared to be the most sensitive test (96%), and may be of use to improve stage determination. 122,123 Other laboratory findings include anemia, increased sedimentation rate, thrombocytopenia, reduced total serum protein, increased serum globulin, and an elevated IgM level which, in the CSF, is pathognomonic for the meningoencephalitic stage of trypanosomiasis. 116,124 African trypanosomiasis should be differentiated from a variety of other diseases, including malaria, influenza, pneumonia, infectious mononucleosis, leukemia, lymphoma, the arbovirus encephalitides, cerebral tumors, and various psychoses.…”